Sometimes some of us get frustrated because it seems that studies have to be done to support the obvious, but I realize that others need experts to validate what seems so simple to try to the rest of us. As a Diabetes Educator talking to patients with both diabetes and …
Read More »Editor’s Note, DCMS #243
When we talk about the complications of diabetes we frequently talk about kidney failure and amputation, but more often than not the first changes that a patient notices are in their vision. Whether it is difficulty reading because of elevated glucose or the first signs of retinopathy, eye changes can …
Read More »Letter from the Editor, #783
Last week in our SGLT- Inhibitor Special Edition for May, we discussed the idea of early adopters using the complete arsenal of diabetes medications for both type 1 and type 2 patients. When I mentioned that one of our advisory board members, Dr. Stanley Schwartz, sets a high bar in using …
Read More »Editor’s Note, SGLT-2 Inhibitors Special Edition, May 2015
Sometimes the early adopters receive a little scorn from their colleagues for "jumping on the bandwagon" too early. However it seems that usually sooner or later everyone else comes over to their way of thinking and the "experimental" becomes the norm. A good example of this is the use of …
Read More »Editor’s Note, DCMS #242
We often threaten our patients with the complications of diabetes to try to get them to work on their diabetes. Kidney failure and dialysis are the most scary ones that we can talk about. But what happens when we finally have to start a patient on dialysis? This week our …
Read More »Letter from the Editor, #782
Steve and I got a chance to talk to Edward Damiano, PhD, from Boston University about his work on the "Bionic Pancreas" while we were at the recent AACE meeting in Nashville. We have all seen a lot of information using CGMS and an insulin pump to automatically adjust insulin …
Read More »Editor’s Note, GLP-1 Analogs May 2015 Special Edition
This past weekend I was at the ADA regional meeting in Orlando. There were over 600 medical professional attendees, and over 40 presentations on medications and of those 28 had content on GLP-1 analogs. I got a chance to share with 200 attendees the real story on how the first …
Read More »Editor’s Note, DCMS #241
We have been at the AACE meeting in Nashville, and the information presented was overwhelming to say the least. Between Steve, Joy, and I we interviewed over 40 thought leaders, practitioners, and researchers so that we can bring you the best of their knowledge. Rather than rush these top professionals, …
Read More »Letter from the Editor, #781
Steve, Joy and I are spending our time at the 24th Annual Scientific and Clinical Conference of the American Association of Clinical Endocrinologists in Nashville, Tennessee. We have spent four days reviewing posters and interviewing the top researchers and practitioners in order to bring you the latest information. We will …
Read More »Editor’s Desk, DCMS #240
When I am discussing the value of physical activity with patients I will often start bending my left ring finger repeatedly and tell the patients that, "I can lower glucose just by doing this. However it is a small muscle and it will take a lot of repetitions." The goal …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.